1. Home
  2. RIG vs RGEN Comparison

RIG vs RGEN Comparison

Compare RIG & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Transocean Ltd (Switzerland)

RIG

Transocean Ltd (Switzerland)

HOLD

Current Price

$4.86

Market Cap

6.9B

Sector

Energy

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$137.95

Market Cap

6.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RIG
RGEN
Founded
1926
1981
Country
Switzerland
United States
Employees
5600
N/A
Industry
Oil & Gas Production
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
6.6B
IPO Year
2008
1995

Fundamental Metrics

Financial Performance
Metric
RIG
RGEN
Price
$4.86
$137.95
Analyst Decision
Hold
Buy
Analyst Count
6
12
Target Price
$7.10
$167.67
AVG Volume (30 Days)
32.4M
1.1M
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
286.96
EPS
0.06
0.15
Revenue
$2,973,000,000.00
$141,236,000.00
Revenue This Year
N/A
$14.30
Revenue Next Year
N/A
$14.52
P/E Ratio
$81.17
$927.07
Revenue Growth
N/A
35.10
52 Week Low
$2.53
$100.99
52 Week High
$7.66
$175.77

Technical Indicators

Market Signals
Indicator
RIG
RGEN
Relative Strength Index (RSI) 27.19 58.18
Support Level $4.75 $130.40
Resistance Level $7.03 $141.46
Average True Range (ATR) 0.20 6.38
MACD -0.06 0.36
Stochastic Oscillator 2.93 52.28

Price Performance

Historical Comparison
RIG
RGEN

About RIG Transocean Ltd (Switzerland)

Transocean Ltd. is an international provider of offshore contract drilling services for oil and gas wells. The company provides mobile offshore drilling rigs, related equipment, and crews to support the drilling of oil and gas wells. Its fleet mainly consists of offshore rigs, including drillships, semisubmersibles, and jackups.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category (about 55% of total revenue), while chromatography, proteins, and process analytics are 21%, 11%, and 13%, respectively. Customers in North America, Europe, and Asia Pacific contribute about 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: